A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
Sponsor
- Conservative Groups$11,211k
- Progressive Groups$1,500k
Full profile: /officials/M001244
Source: Congress.gov · FEC
Cosponsors (3)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
3 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2026-07-21
Source: Congress.gov
Committee Activity
Currently in
- Senate Committee on Health, Education, Labor, and PensionsReferred To · 2026-07-21
Plain-English Summary
Plain-English summary pending. Introduced on 2026-07-21. Check back soon — summaries are generated as bills progress through Congress.
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S5058A bill to amend title 49, United States Code, to prohibit staged collisions with commercial motor vehicles, and for other purposes.Referred to Committee · 2026-07-21
- S5001A bill to amend the Help America Vote Act of 2002 to require ballots in elections for Federal office to be received by the close of the polls on the date of election.Referred to Committee · 2026-07-15
- S4905Space Ready 2.0 ActReferred to Committee · 2026-06-24
- S4907TRADES ActReferred to Committee · 2026-06-24